ストックスクリーナーアプリを入手
2.09
0.97%
0.02
アフターアワーズ：
2.12
0.03
+1.44%
Mustang Bio Inc (MBIO) 最新ニュース
Is Mustang Bio Inc. a good long term investmentFree Stock Selection - Autocar Professional
What analysts say about Mustang Bio Inc. stockUnprecedented profits - jammulinksnews.com
Mustang Bio Inc. Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
What drives Mustang Bio Inc. stock priceExtraordinary profit generation - jammulinksnews.com
Mustang Bio (NASDAQ:MBIO) Upgraded to “Hold” at Wall Street Zen - Defense World
How Mustang Bio Inc. stock performs during market volatility200 Percent Gain Alert - Newser
Why Mustang Bio Inc. stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser
What makes Mustang Bio Inc. stock price move sharplyTriple Digit Return Forecasts - Newser
MBIO Stock: Exploring Mustang Bio Inc’s Growth - investchronicle.com
Mustang Bio Shares Skyrocket After Orphan Drug Designation - StocksToTrade
Mustang Bio’s Shares Skyrocket as FDA Grants Orphan Drug Designation - timothysykes.com
Promising Small Cap Stocks Worth Watching – July 7th - Defense World
Top Penny Stocks To Follow Now – July 7th - Defense World
Mustang Bio’s Meteoric Surge: What’s Driving Up MBIO? - StocksToTrade
Mustang Bio’s Stock Soars: What’s Driving the Surge? - timothysykes.com
Mustang Bio Receives FDA Orphan Drug Designation - TipRanks
Best Medical Stocks To Follow Today – July 7th - Defense World
Promising Pharmaceutical Stocks To Consider – July 7th - Defense World
Top Biotech Stocks To Research – July 7th - Defense World
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On - Benzinga
Mustang Bio Ignites Bullish Retail Buzz As FDA Grants Orphan Status To Brain Cancer Drug - NewsBreak: Local News & Alerts
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - TradingView
Mustang Bio Stock Jumps 180% After FDA Grants Orphan Drug Status to Brain Cancer Drug - inkl
Why Did Mustang Bio Plunge 11.68% After 196.21% Surge? - AInvest
Biotech Stock Analysis: MBIO Soars after FDA Grants Orphan Drug Designation - Markets.com
Market Wrap | US Stocks Slide as Fed Rate Cut Hints Emerge Palantir and Mustang Bio Soar - AInvest
Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation - Benzinga
Dow Dips 1%; Mustang Bio Shares Spike Higher - inkl
This BlackRock stock just spiked over 300% - Finbold
Mustang Bio Stock Surges: Time to Reconsider? - StocksToTrade
FDA grants orphan drug status to Mustang Bio’s glioma treatment By Investing.com - Investing.com Canada
Mustang Bio’s Drastic Turn: Opportunity or Red Flag? - timothysykes.com
Mustang Bio rises after FDA orphan drug status for MB-101 - Seeking Alpha
Mustang Bio stock soars after FDA grants orphan drug designation By Investing.com - Investing.com South Africa
Mustang Bio stock soars after FDA grants orphan drug designation - Investing.com
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - The Manila Times
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire
Breakthrough Brain Cancer Treatment: FDA Backs Mustang Bio Therapy After 66-Month Complete Response in Trials - Stock Titan
0.51%
大文字化:
|
ボリューム (24 時間):